港股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

派格生物医药-B

61.600

+0.9001.48%

成交量：2.60万

成交额：160.40万

市值：237.78亿

市盈率：-72.96

高：62.300

开：60.700

低：60.700

收：60.700

52周最高：72.750

52周最低：8.680

股本：3.86亿

香港流通股本：2.79亿

量比：3.01

换手率：0.01%

股息：- -

股息率：- -

每股收益(LYR):-0.844

净资产收益率：-224.15%

总资产收益率：-61.30%

市净率：85.21

市盈率(LYR):-72.96

市销率: -5612.07

数据加载中...

总览公司新闻资讯公告

9轮融资、众多头部机构加持，减肥药明星企业今日IPO

新股定价 | 派格生物医药每股定价15.6港元，公开发售获743.78倍认购，一手中签率8%

老虎资讯综合

港股IPO动态：今日派格生物医药-B、吉宏股份上市

派格生物医药-B香港公开发售获743.78倍认购，发售价为每股15.6港元

老虎暗盘｜派格生物医药-B跌近4%，中签一手亏300港元

老虎资讯综合

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/02565/news?page=5"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"02565","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","market":"HK","secType":"STK","nameCN":"派格生物医药-B","latestPrice":61.6,"timestamp":1763429811235,"preClose":60.7,"halted":0,"volume":26000,"delay":0,"floatShares":279164339,"shares":386000000,"eps":-0.8443522371860155,"marketStatus":"交易中","change":0.9,"latestTime":"11-18 09:37:18","open":60.7,"high":62.3,"low":60.7,"amount":1604025,"amplitude":0.026359,"askPrice":61.65,"askSize":500,"bidPrice":61.35,"bidSize":1000,"shortable":3,"etf":0,"ttmEps":-0.6569012449447635,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1763438400000},"marketStatusCode":2,"adr":0,"listingDate":1748275200000,"exchange":"SEHK","adjPreClose":60.7,"openAndCloseTimeList":[[1763429400000,1763438400000],[1763442000000,1763452800000]],"volumeRatio":3.012556,"lotSize":500,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"02565\",,,,,undefined,":{"symbol":"02565","floatShares":279164339,"roa":"-61.30%","roe":"-224.15%","lyrEps":-0.844352,"volumeRatio":3.012556,"shares":386000000,"dividePrice":0,"high":62.3,"amplitude":0.026359,"preClose":60.7,"low":60.7,"week52Low":8.68,"pbRate":"85.21","psRate":"-5612.07","week52High":72.75,"institutionHeld":0,"latestPrice":61.6,"committee":0.333333,"eps":-0.8443522371860155,"divideRate":0,"volume":26000,"delay":0,"ttmEps":-0.6569012449447635,"open":60.7,"prevYearClose":15.6,"prevWeekClose":63.25,"prevMonthClose":60.1,"prevQuarterClose":54.2,"fiveDayClose":53,"twentyDayClose":53.9,"sixtyDayClose":31.8},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/02565\",params:#limit:5,,,undefined,":[{"date":"2025-08-26","symbol":"02565","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756171800000,"name":null,"time":"","dateTimestamp":1756137600000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"02565\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"02565\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":0,"sell":0,"strongSell":1,"meanLabel":"STRONG SELL","meanPercent":1,"analysts":1,"updateTime":1755446400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/02565\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"02565","date":"2025-11-14","current":-92.37825,"percent":0,"low":-72.819022,"twenty":-61.035505,"median":-39.959751,"eighty":-12.906561,"high":-11.114373,"avg":-37.222505,"sd":22.07937,"marketCap":17657144441},"quantilePoints":[{"date":"2025-05-30","current":-12.743079,"twenty":-15.470266,"median":-13.542645,"eighty":-13.135794,"marketCap":3936746426},{"date":"2025-06-06","current":-11.987888,"twenty":-13.726785,"median":-12.740515,"eighty":-12.114178,"marketCap":3712892217},{"date":"2025-06-13","current":-11.23576,"twenty":-13.295707,"median":-12.114337,"eighty":-11.528404,"marketCap":3481318898},{"date":"2025-06-20","current":-11.30775,"twenty":-12.841258,"median":-11.963331,"eighty":-11.337793,"marketCap":3496757119},{"date":"2025-06-27","current":-12.421214,"twenty":-12.738977,"median":-11.541778,"eighty":-11.292079,"marketCap":3851836209},{"date":"2025-07-04","current":-13.963875,"twenty":-12.971799,"median":-11.987888,"eighty":-11.299391,"marketCap":4330421069},{"date":"2025-07-11","current":-13.604213,"twenty":-13.050401,"median":-12.199189,"eighty":-11.305737,"marketCap":4214634409},{"date":"2025-07-18","current":-16.956264,"twenty":-13.748078,"median":-12.438987,"eighty":-11.330282,"marketCap":5248995235},{"date":"2025-07-25","current":-19.006677,"twenty":-15.472199,"median":-12.742066,"eighty":-11.352726,"marketCap":5905119639},{"date":"2025-08-01","current":-19.199848,"twenty":-18.276271,"median":-12.906561,"eighty":-11.424474,"marketCap":5928276971},{"date":"2025-08-08","current":-20.51103,"twenty":-19.019895,"median":-13.05938,"eighty":-11.472546,"marketCap":6348968501},{"date":"2025-08-15","current":-39.959751,"twenty":-19.179784,"median":-13.542645,"eighty":-11.515029,"marketCap":12350577024},{"date":"2025-08-22","current":-41.864246,"twenty":-19.284777,"median":-13.964282,"eighty":-11.779976,"marketCap":12898633879},{"date":"2025-08-29","current":-41.44792,"twenty":-21.432837,"median":-14.946806,"eighty":-11.968242,"marketCap":10033166343},{"date":"2025-09-05","current":-50.678037,"twenty":-39.039264,"median":-17.018603,"eighty":-12.06328,"marketCap":12255314482},{"date":"2025-09-12","current":-58.538001,"twenty":-40.749762,"median":-18.438762,"eighty":-12.114019,"marketCap":14181548421},{"date":"2025-09-19","current":-57.311117,"twenty":-43.720929,"median":-18.952908,"eighty":-12.216159,"marketCap":13874467648},{"date":"2025-09-26","current":-63.587749,"twenty":-49.33228,"median":-19.070122,"eighty":-12.366345,"marketCap":15354038645},{"date":"2025-10-03","current":-60.149194,"twenty":-54.575673,"median":-19.16943,"eighty":-12.428323,"marketCap":14558420278},{"date":"2025-10-10","current":-60.121463,"twenty":-57.957283,"median":-19.199848,"eighty":-12.49878,"marketCap":14530503844},{"date":"2025-10-17","current":-60.168303,"twenty":-59.756564,"median":-19.2984,"eighty":-12.738571,"marketCap":14530503844},{"date":"2025-10-24","current":-61.301982,"twenty":-60.143648,"median":-20.51103,"eighty":-12.741458,"marketCap":14809668183},{"date":"2025-10-31","current":-69.345185,"twenty":-60.159469,"median":-22.018639,"eighty":-12.743079,"marketCap":16777776773},{"date":"2025-11-07","current":-59.401661,"twenty":-60.392128,"median":-34.33922,"eighty":-12.780248,"marketCap":14363005241},{"date":"2025-11-14","current":-72.819022,"twenty":-61.035505,"median":-39.959751,"eighty":-12.906561,"marketCap":17657144441}],"updateTime":1763398128357},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"02565\",pageSize:20,pageCount:5,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2538348603","title":"9轮融资、众多头部机构加持，减肥药明星企业今日IPO","url":"https://stock-news.laohu8.com/highlight/detail?id=2538348603","media":"动脉网","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538348603?lang=zh_cn&edition=fundamental","pubTime":"2025-05-27 08:09","pubTimestamp":1748304549,"startTime":"0","endTime":"0","summary":"在火热的T2DM及减肥赛道，派格生物是一级市场的明星项目。招股书显示，在IPO之前，派格生物于2008年至2023年之间先后获得9轮融资，投资方包括元生创投、泰格医药、盈科资本、前海、君联资本等一众知名机构与企业。初步研究结果表明，PB-718可减少肝脏中的脂质积累，从而防止肝脏炎症和随后出现的肝纤维化。截至2025年2月，国内已有15款用于治疗T2DM的GLP-1药物，以及6款用于肥胖症的药物。此外，也有GLP-1减重药物将医美机构纳入营销网络。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527081209a6ee13e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527081209a6ee13e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["03347","BK1141","02565","BK1583","BK1576"],"gpt_icon":1},{"id":"1146090593","title":"新股定价 | 派格生物医药每股定价15.6港元，公开发售获743.78倍认购，一手中签率8%","url":"https://stock-news.laohu8.com/highlight/detail?id=1146090593","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146090593?lang=zh_cn&edition=fundamental","pubTime":"2025-05-27 08:05","pubTimestamp":1748304305,"startTime":"0","endTime":"0","summary":" $派格生物医药-B(02565)$ 公布招股结果，香港公开发售接获743.78倍认购，一手(500股)中签率8%，认购10万股始获稳派一手。按回补机制，公开发售股份已增至964.2万股，占发售总数50%。国际配售录得1.13倍认购。发售价15.6港元，集资净额2.32亿港元元。股份预期周二(27日)上市。生物技术公司派格生物医药本次拟全球发售1,928.35万股，香港公开发售原占10%。基石投资者益泽康瑞旗下益泽康瑞医药(香港)获分配958.45万股，占发售後H股股本3.43%。","market":"hk","thumbnail":"https://community-static.tradeup.com/news/8fe389b09b53c9beb073f83ce44ec0c0","type":0,"news_type":0,"thumbnails":["https://community-static.tradeup.com/news/8fe389b09b53c9beb073f83ce44ec0c0"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9def1a2fcaf9e5fd93e233e38a747185","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":"派格生物医药每股定价15.6港元，公开发售超购742倍，一手中签率8%","news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"gpt_icon":0},{"id":"2538483695","title":"港股IPO动态：今日派格生物医药-B、吉宏股份上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2538483695","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538483695?lang=zh_cn&edition=fundamental","pubTime":"2025-05-27 06:06","pubTimestamp":1748297201,"startTime":"0","endTime":"0","summary":"格隆汇5月27日｜今日派格生物医药-B(2565.HK)、吉宏股份(2603.HK)上市，手回集团(2621.HK)处于申购期。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527060705976655f3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250527060705976655f3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02603","02565","HSCEI","HSTECH"],"gpt_icon":0},{"id":"2538056551","title":"派格生物医药-B香港公开发售获743.78倍认购，发售价为每股15.6港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538056551","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2538056551?lang=zh_cn&edition=fundamental","pubTime":"2025-05-26 20:07","pubTimestamp":1748261268,"startTime":"0","endTime":"0","summary":"智通财经APP讯，派格生物医药-B(02565)公布配发结果，全球发售项下发售1918.35万股，其中香港公开发售的发售股份数目为964.2万股，国际发售的发售股份数目为964.15万股;最终发售价为每股15.6港元，全球发售净筹约2.32亿港元，每手500股，预期H股将于香港时间2025年5月27日(星期二)上午九时正开始在联交所买卖。其中，香港公开发售获743.78倍认购，国际发售获1.13倍认购。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9def1a2fcaf9e5fd93e233e38a747185","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1297723.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02565","161726","399441"],"gpt_icon":0},{"id":"1125385100","title":"老虎暗盘｜派格生物医药-B跌近4%，中签一手亏300港元","url":"https://stock-news.laohu8.com/highlight/detail?id=1125385100","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1125385100?lang=zh_cn&edition=fundamental","pubTime":"2025-05-26 16:15","pubTimestamp":1748247330,"startTime":"0","endTime":"0","summary":"5月26日，$派格生物医药-B$暗盘跌近4%，报15港元/股，中签一手亏300港元；公司每股定价15.6港元，每手500股，将于5月27日（周二）正式挂牌交易。PB-119主要用于T2DM及肥胖症一线治疗。按发售价为每股H股15.60港元计算，全球发售总净所得款项约为2.318亿港元。杭州拱墅是一家于2018年在中国成立的有限公司。其已投资超过30家公司，总投资额超过人民币25亿元。杭州拱墅已同意就基石投资者认购基石配售项下的发售股份担任其担保人。","market":"hk","thumbnail":"https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6b69e234a63c2c0a69ccede7b0faaa18"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"b2619d86031d9f015a3a3bab995ddbeb","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["02565"],"gpt_icon":1}],"pageSize":20,"totalPage":5,"pageCount":5,"totalSize":85,"code":"91000000","status":"200"}]}}